Navigation Links
NCCN Emphasizes Tailored Treatment in Discovery Health Channel Program Metastatic Breast Cancer: Individualizing Treatment
Date:11/20/2009

NCCN program on Discovery Health Channel profiles patients undergoing treatment for metastatic breast cancer and their physicians' use of the NCCN Clinical Practice Guidelines in Oncology(TM) for Breast Cancer to determine an individualized treatment regimen. The program, which provides free CME credits, premieres on Sunday, November 22 at 7:00 am EST.

FORT WASHINGTON, Pa., Nov. 20 /PRNewswire-USNewswire/ -- Although October (National Breast Cancer Awareness Month) is behind us, it remains imperative for both physicians and patients to keep up-to-date on the latest treatment developments for breast cancer, as well as all types of cancer. Metastatic breast cancer is breast cancer that has spread beyond the breast into places such as the bones, lungs, liver, or brain. Although metastatic breast cancer is not curable, there are many effective treatments, including a number of recent treatment advances that are enabling women with metastatic breast cancer to live longer and better lives. However, treatment needs to be highly individualized as no single treatment plan is right for everyone.

The National Comprehensive Cancer Network (NCCN), a not-for-profit alliance of 21 of the world's leading cancer centers, has collaborated with the Discovery Health Channel to produce a program profiling three patients with metastatic breast cancer and their healthcare team as they customize each patient's treatment regimen to their individual tumor type and health status. The program, Metastatic Breast Cancer: Individualizing Treatment, premieres Sunday, November 22, 2009 at 7 am EST on the Discovery Health Channel. This program is available for Continuing Medical Education (CME/CE) credits for physicians as well as nurses.

"Discovery Health is thrilled to continue its ongoing partnership with the National Comprehensive Cancer Network and the launch of this incredibly valuable and timely program," said John Whyte, MD, Vice President, Continuing Medical Education and Chief Medical Expert, Discovery Health. "This collaboration directly aligns with Discovery Health's mission to deliver credible, high-quality Continuing Medical Education content to physicians and health care providers."

NCCN is known for developing the NCCN Clinical Practice Guidelines in Oncology(TM), a leading clinical reference for health care providers around the globe. This program will include members of the NCCN Guidelines Panel for Breast Cancer as they explore individualizing treatment for patients with metastatic breast cancer and focus on evolving data for the disease and the application in the current NCCN Guidelines.

Featured faculty includes:

  • William J. Gradishar, MD - Robert H. Lurie Comprehensive Cancer Center of Northwestern University
  • Beryl McCormick, MD - Memorial Sloan-Kettering Cancer Center
  • John H. Ward, MD - Huntsman Cancer Institute at the University of Utah

Current air dates for Metastatic Breast Cancer: Individualizing Treatment, please check your local listings for the most current schedule (all times are EST):

  • Sunday, November 22 - 7:00 am (premiere)
  • Saturday, November 28 - 7:00 am
  • Sunday, November 29 - 6:00 am
  • Sunday, December 6 - 6:00 am
  • Saturday, December 12 - 7:00 am
  • Sunday, December 27 - 6:00 am

For additional information about the program and available CME/CE credits, visit NCCN.org or DiscoveryHealthCME.com.

About the National Comprehensive Cancer Network

The National Comprehensive Cancer Network (NCCN), a not-for-profit alliance of 21 of the world's leading cancer centers, is dedicated to improving the quality and effectiveness of care provided to patients with cancer. Through the leadership and expertise of clinical professionals at NCCN Member Institutions, NCCN develops resources that present valuable information to the numerous stakeholders in the health care delivery system. As the arbiter of high-quality cancer care, NCCN promotes the importance of continuous quality improvement and recognizes the significance of creating clinical practice guidelines appropriate for use by patients, clinicians, and other health care decision-makers. The primary goal of all NCCN initiatives is to improve the quality, effectiveness, and efficiency of oncology practice so patients can live better lives.

The NCCN Member Institutions are: City of Hope, Los Angeles, CA; Dana-Farber/Brigham and Women's Cancer Center / Massachusetts General Hospital Cancer Center, Boston, MA; Duke Comprehensive Cancer Center, Durham, NC; Fox Chase Cancer Center, Philadelphia, PA; Huntsman Cancer Institute at the University of Utah, Salt Lake City, UT; Fred Hutchinson Cancer Research Center/Seattle Cancer Care Alliance, Seattle, WA; The Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins, Baltimore, MD; Robert H. Lurie Comprehensive Cancer Center of Northwestern University, Chicago, IL; Memorial Sloan-Kettering Cancer Center, New York, NY; H. Lee Moffitt Cancer Center & Research Institute, Tampa, FL; The Ohio State University Comprehensive Cancer Center - James Cancer Hospital and Solove Research Institute, Columbus, OH; Roswell Park Cancer Institute, Buffalo, NY; Siteman Cancer Center at Barnes-Jewish Hospital and Washington University School of Medicine, St. Louis, MO; St. Jude Children's Research Hospital/University of Tennessee Cancer Institute, Memphis, TN; Stanford Comprehensive Cancer Center, Stanford, CA; University of Alabama at Birmingham Comprehensive Cancer Center, Birmingham, AL; UCSF Helen Diller Family Comprehensive Cancer Center, San Francisco, CA; University of Michigan Comprehensive Cancer Center, Ann Arbor, MI; UNMC Eppley Cancer Center at The Nebraska Medical Center, Omaha, NE; The University of Texas

M. D. Anderson Cancer Center, Houston, TX; and Vanderbilt-Ingram Cancer Center, Nashville, TN. For more information, visit NCCN.org.

About Discovery Health CME:

Discovery Health CME (Continuing Medical Education) offers an entirely new way to learn about the latest advances in medicine. Medical professional are eligible to receive CME credits for viewing METASTIC BREAST CANCER: INDIVIDUALIZING TREATMENT. More information is available at DiscoveryHealthCME.com.

SOURCE National Comprehensive Cancer Network


'/>"/>
SOURCE National Comprehensive Cancer Network
Copyright©2009 PR Newswire.
All rights reserved

Related medicine news :

1. Vioxx Disclosure Emphasizes Need for New Web Resource that Answers Questions About Anti-Epileptic Medication Use
2. AHCA Emphasizes Quality Improvement in Americas Nursing Homes
3. Photos: Georgia Pecan Campaign Emphasizes Nutritional Importance of Breakfast
4. As Chairman Baucus Outlines Vision for Healthcare Reform, NACDS Emphasizes Pharmacy's Essential Role in Any Successful Overhaul
5. American College of Surgeons Issues New Health Care Reform Agenda, Emphasizes Need to Address Access, Surgical Workforce Shortage
6. PA Education Secretary Emphasizes Importance of Breakfast for Student Performance
7. Milliman Care Guidelines(R) 2009 Release Emphasizes Efficiency, Quality Solutions
8. American Society for Microbiology Emphasizes Hand Hygiene as Flu Protective Measure
9. New Report Emphasizes Critical Role of Including Early and Preventative Care for Women in Health Care Reform
10. OMTECs Opening Keynote Emphasizes Increasing Demand for Orthopaedic Procedures
11. New AMA Ad Emphasizes Common Ground on Health Reform, Shares Vision to Fix Broken System
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/8/2016)... ... 08, 2016 , ... Brenntag Specialties, Inc.(BSI) , is ... & Beverage and Dietary Supplement market segments across the western ... geographies east of the Rocky Mountains since 2012. Consistent performance in business ...
(Date:2/8/2016)... ... ... The Valentine’s Season is famous for gift giving with flowers, chocolates and other tokens of ... This year, for more than 5.6 million Americans suffering with Alzheimer’s, those store bought gifts ... them of the lives they’ve led and the people they’ve touched. , That’s ...
(Date:2/8/2016)... ... February 08, 2016 , ... If you are feeling ... handle, you are not alone. According to the Center for Disease Control and Prevention ... type 2 diabetes and certain types of cancer, some of the leading causes of ...
(Date:2/8/2016)... ... 2016 , ... The Bell Agency, a full service insurance ... their ongoing community enrichment program. The current campaign fundraises for Angels & Doves, ... being accepted at: http://www.angelsanddoves.com/donate.html . , Angels & Doves was founded in ...
(Date:2/8/2016)... ... February 08, 2016 , ... ... networking and relationship-marketing firm, announced today that nominations will be accepted February ... (ISE®) West Awards. , Awards include the Information Security Executive® of ...
Breaking Medicine News(10 mins):
(Date:2/9/2016)... Mast Therapeutics, Inc. (NYSE MKT: MSTX), a biopharmaceutical ... heart failure, today announced that it intends to offer shares ... an underwritten public offering.  The offering is subject to market ... to whether or when the offering may be completed, or ...   --> --> Roth ...
(Date:2/9/2016)... 9, 2016 Hearing protection devices refer to ... transmitted to the inner ear. Hearing protection devices include ... devices are recommended for users exposed to noise levels ... to HPD that are inserted in the ear canal ... to provide more natural sound perception with the help ...
(Date:2/9/2016)... This TforG report includes the Surgical Procedures Database with ... in South Korea . To add ... written and numerical analysis on the current trends, size, ... latest reforms of the local Healthcare system are clearly ... The report helps businesses gain a unique insight into ...
Breaking Medicine Technology: